logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Healthcare Services
Filter

Healthcare Services

Categories

Sectors

Locations

Exchange

吉利德 Forty Seven

Gilead to Acquire Immuno-Oncology Company Forty Seven for $4.9 Billion

Mar 2, 2020

Life Science

Generex 北京中华 冠状病毒 疫苗

Generex Signs Contract with Chinese Partners Beijing Zhonghua Investment Fund Management Co., LTD and Sinotek-Advocates International Industry Development (Shenzhen) Co., Ltd. to Develop a COVID-19 Vaccine Using Ii-Key Peptide Vaccine Technology

Mar 2, 2020

Life Science

四环医药 冠状病毒

Sihuan Pharma Starts China Trials of Favipiravir to Treat COVID-19

Mar 2, 2020

Life Science

医疗保健精选——冠状病毒推高股价,赛诺菲为慈善调查案支付1,185万美元和解费

Healthcare Roundup – Another big session in store for coronavirus names,Sanofi to pay $11.85M to resolve drug charity probe

Feb 28, 2020

Life Science

Berkeley Lights 新冠肺炎

Researchers Worldwide Are Using Berkeley Lights’ Beacon Platform To Combat COVID-19

Feb 28, 2020

Life Science

准确率超高! 平安新冠肺炎智能阅片系统助疫区医生更高效

Ping An Launches COVID-19 Smart Image-Reading System to Help Control the Epidemic

Feb 28, 2020

Life Science

突破!马痘病毒疫苗或许能预防新冠肺炎,Tonix Pharmaceuticals 已取得进展

Tonix Pharmaceuticals Announces Research Collaboration with Southern Research to Develop a Potential Vaccine to Protect Against New Coronavirus Disease 2019 (COVID-19) Based on Horsepox Virus (TNX-1800)

Feb 26, 2020

Life Science

吉利德 瑞德昔韦 谷歌 1Life

Healthcare Roundup – Clinical trial of Gilead’s remdesivir in Covid-19 starts, Google-backed 1Life draws analyst praise

Feb 25, 2020

Life Science

上海美国商会 新冠肺炎

Mainland China Reports 406 New Cases of Coronavirus on Feb 25, Deaths up by 52

Feb 25, 2020

Life Science

Vir Biotechnology and WuXi Biologics Announce Collaboration for Global Development of Antibodies to Treat COVID-19

Feb 25, 2020

Life Science

中国日产逾170万份新冠肺炎检测试剂

China Makes Over 1.7 Million Covid-19 Testing Kits per Day, Official Says

Feb 24, 2020

Life Science

Invetx 融资

Invetx Announces $15 Million Series A Financing and Industry-leading Partnerships for Animal Biopharmaceutical Development

Feb 24, 2020

Life Science

新冠肺炎疫苗研发!中国三叶草生物与葛兰素史克合作评估候选疫苗

Clover and GSK Announce Research Collaboration to Evaluate Coronavirus (COVID-19) Vaccine Candidate with Pandemic Adjuvant System

Feb 24, 2020

Life Science

Healthcare Roundup – Gilead gains 4.8% as WHO sees potential in its antiviral drug, Moderna ships first batch of coronavirus vaccine for human trials

Feb 24, 2020

Life Science

损失1680亿美元!新冠肺炎下的中国旅游业苦

Coronavirus to Cost China Tourism USD168 Billion in 2020, Academy Predicts

Feb 21, 2020

Life Science

中国依图研发新冠肺炎疫情AI医疗防控产品

Efficient Assistance, YITU AI Aids Epidemic Prevention and Control of COVID-19 Outbreak

Feb 21, 2020

Life Science

医疗保健精选——全球有近7.7万新冠肺炎患者,Curaleaf进军宾夕法尼亚州

Healthcare Roundup – Coronavirus cases almost 77K globally, Curaleaf on go to establish presence in Pennsylvania  

Feb 21, 2020

Life Science

中国 疫情 业务

‘China is still China’ so start making post-epidemic business plans, experts say

Feb 20, 2020

Life Science

  • ‹‹ Previous
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada